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Abstract
Background: Caveolae are involved in diverse cellular functions such as signal transduction,
cholesterol homeostasis, endo- and transcytosis, and also may serve as entry sites for
microorganisms. Hence, their occurrence in epithelium of the airways might be expected but,
nonetheless, has not yet been examined.
Methods: Western blotting, real-time quantitative PCR analysis of abraded tracheal epithelium
and laser-assisted microdissection combined with subsequent mRNA analysis were used to
examine the expression of cav-1 and cav-2, two major caveolar coat proteins, in rat tracheal
epithelium. Fluorescence immunohistochemistry was performed to locate caveolae and cav-1 and
-2 in the airway epithelium of rats, mice and humans. Electron-microscopic analysis was used for
the identification of caveolae. CLSM-FRET analysis determined the interaction of cav-1α and cav-2
in situ.
Results: Western blotting and laser-assisted microdissection identified protein and transcripts,
respectively, of cav-1 and cav-2 in airway epithelium. Real-time quantitative RT-PCR analysis of
abraded tracheal epithelium revealed a higher expression of cav-2 than of cav-1. Immunoreactivities
for cav-1 and for cav-2 were co-localized in the cell membrane of the basal cells and basolaterally
in the ciliated epithelial cells of large airways of rat and human. However, no labeling for cav-1 or
cav-2 was observed in the epithelial cells of small bronchi. Using conventional double-labeling
indirect immunofluorescence combined with CLSM-FRET analysis, we detected an association of
cav-1α and -2 in epithelial cells. The presence of caveolae was confirmed by electron microscopy.
In contrast to human and rat, cav-1-immunoreactivity and caveolae were confined to basal cells in
mice. Epithelial caveolae were absent in cav-1-deficient mice, implicating a requirement of this
caveolar protein in epithelial caveolae formation.
Conclusion: These results show that caveolae and caveolins are integral membrane components
in basal and ciliated epithelial cells, indicating a crucial role in these cell types. In addition to their
physiological role, they may be involved in airway infection.
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Background
Caveolae are omega-shaped invaginations of the plasma
membrane measuring 50 to 100 nm in diameter. They are
found in numerous cell types such as type I pneumocytes,
endothelial cells, adipocytes, fibroblasts, smooth muscle
cells, cardiac and striated muscle cells [1]. Caveolar forma-
tion is dependent on the expression of caveolins. Three
caveolins (cav) are known. Cav-1 and cav-2 are widely
expressed, whereas cav-3 is thought to be restricted to
muscle cells [2]. Cav-1 is expressed in two isoforms, cav-
1α and cav-1β, exhibiting a cell type-specific distribution
(endothelial vs. alveolar type-1 cells) in the alveolar
region [3].
Caveolae are involved in diverse cellular functions such as
organizing signal transduction mechanisms, endocytosis
and intracellular transport [2]. Several pathogenic micro-
organisms selectively use caveolae to enter cells [4]. After
accumulation in the caveolae, they are delivered to the
endoplasmatic reticulum bypassing the classical endo-
some-lysosome trafficking and thereby preventing inacti-
vation [5,6]. It has been shown that the infectivity of C-
type human adenovirus can be greatly reduced by the
expression of a dominant negative cav-1 mutant in plas-
mocytic cells [7], indicating that caveolae are involved in
this process. In addition, it was recently shown for
Chlamydia pneumoniae that it co-localizes intracellularly
with cav-1 and cav-2 after infection, and a role of these
proteins for the developmental cycle of Chlamydiae is dis-
cussed [8]. Also, the human coronavirus 229E that is
known to induce respiratory tract infections enters cells
via a caveolae dependent mechanism [9,10].
Although the airway epithelium serves as entry site for
microbes, fulfils functions that are associated with caveo-
lae such as endo- and transcytosis, and harbors receptors
that are associated with caveolae [1], the expression of
caveolins, their interaction, and the presence of caveolae
in tracheal and bronchial epithelial cells have not yet been
determined. Interestingly, the presence of "vesicles that
sometimes are connected with the membrane" has earlier
been described at the electron-microscopic level in mouse
basal cells [11]. Moreover cav-1 and cav-2 were detected in
cell lines derived from bronchial epithelium [12], point-
ing to the presence of caveolae in the airway epithelium.
Both cav-1 and cav-2 exhibit a similar expression, but
seem to have different functions. Cav-1 is sufficient to
drive caveolar formation [13]. In general, it is thought that
cav-2 alone is not sufficient for caveolae formation, and
the absence of caveolae in cav-1-deficient mice is associ-
ated with marked reduction in cav-2 levels [14]. In con-
trast, although caveolae are still present in cav-2 deficient
mice, these mice show the marked pathological alveolar
phenotype of cav-1 deficient mice [15]. This indicates that
cav-2, although not able to form caveolae on its own, has
profound influences on caveolar function. Since a selec-
tive association of cav-2 but not cav-1 was described with
Chlamydia species other than Chlamydia pneumoniae it
is likely that both proteins can have divergent functions
during infectious processes making it necessary to exam-
ine the presence and localization of both proteins.
In view of these facts, it is pivotal to gain insight in the cel-
lular expression of caveolae and caveolins in bronchial
and tracheal epithelium. We therefore examined the
expression of cav-1 and cav-2 on the mRNA and protein
level, determined the distribution of cav-1α, cav-1β, and
cav-2 by immunohistochemistry and examined the pres-
ence of caveolae by electron microscopy. To address the
molecular composition of caveolae, we determined the
molecular association of cav-1α and cav-2 in tracheal epi-
thelial cells in tissue sections by double-labeling indirect
immunofluorescence combined with confocal laser scan-
ning microscopy (CLSM) and fluorescence resonance
energy transfer (FRET) analysis.
Methods
Animals
This study was performed on 1) Wistar rats (150–250 g)
of either sex, kept either under standard laboratory condi-
tions or under specified pathogen-free (SPF) conditions,
and 2) cav-1-deficient mice [14] and the corresponding
C57/Bl6 wild-type mice that were kept under SPF condi-
tions. The animals were held according to the German
guidelines for the care and use of laboratory animals. They
were killed by inhalation of an overdose of isoflurane
(Abbott, Wiesbaden, Germany).
RT-PCR
Total RNA from abraded tracheal epithelial cells of adult
Wistar rats (n = 6) was isolated by using the RNeasy
method according to the manufacturer'sprotocol (Qiagen,
Hilden, Germany). The epithelial cells from the trachea
were abraded using cotton swabs that were carefully rolled
over the epithelial layer. Contaminating DNA was
degraded using 1 U DNase-I (Invitrogen, Karlsruhe, Ger-
many) per µg of total RNA, and reverse transcription was
done for 50 min at 42°C using 200 U Superscript II
reverse transcriptase (Invitrogen) per µg of RNA. RT-PCR
was performed by adding 1 µl cDNA, 0.5 µl of each gene-
specific intron-spanning primer pair for cav-1 or cav-2 (20
pM; MWG Biotech, Ebersberg, Germany, Table 1), 2.5 µl
10 × PCR buffer II (100 mM Tris-HCl, 500 mM KCl, pH
8.3), 2 µl MgCl2 (15 mM), 0.5 µl dNTP (10 mM each), 0.1
µl AmpliTaqGold polymerase (5 U/µl; all reagents from
Applied Biosystems, Darmstadt, Germany) and 17.9 µl
H2O. Cycling conditions were 12 min at 95°C,40 cycles
with 30 s at 95°C, 30 s at 59°C,30 s at 72°C, and a final
extension at 72°C for 7 min. Control reactions includedRespiratory Research 2006, 7:108 http://respiratory-research.com/content/7/1/108
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the absence of DNA template and the absence of reverse
transcriptase. Primers for β-2-microglobulin (β-MG) were
used as a positive control for efficiency of RNA isolation
and cDNA synthesis. The PCR products were separated by
electrophoresis on a 2% TRIS-acetate-EDTA agarose gel.
Real time RT-PCR
Total RNA was isolated from abraded tracheal epithelial
cells of rats (n = 6, SPF; n = 3, standard conditions) and
reverse-transcribed as described above. Real-time PCR was
performed in an I-Cycler (Bio-Rad, Munich, Germany)
using a QuantiTec SYBR Green PCR kit (Qiagen). Primer
sets for cav-1 and -2 amplifying the sequences correspond-
ing to nucleotides 25–147 and 392–497, respectively,
were used (Table 1). The PCR conditions included initial
denaturation in one cycle of 10 min at 95°C followed by
40 cycles of 20 s at 95°C, 20 s at 59°C, and 20 s at 72°C.
All analyses were done in triplicate. As a basis for the rela-
tive mRNA quantification, the mean cycle thresholds (CT)
for cav-1 and cav-2 were calculated. The corresponding
threshold cycles of the target gene were subtracted from
mean β-MG-CT according to:
∆CT = CTtarget gene – CTβ-MG
The relative expression (RE) of cav-2 compared to that of
cav-1 was calculated as follows:
REcav-2 = 2∆∆CTcav-2, where
∆∆CTcav-2 = ∆CTcav-1 - ∆CTcav-2.
The PCR products were analyzed by electrophoresis on a
2% TRIS-acetate-EDTA agarose gel.
Laser-assisted microdissection and subsequent RT-PCR
Laser-assisted microdissection (using a MicroBeam Sys-
tem, P.A.L.M. Microlaser Technologies, Bernried, Ger-
many) was used to isolate epithelial cells from
cryosections of tracheae of rats (SPF, n = 6; normal condi-
tions, n = 2). Serial cryosections (6 µm) were collected on
membrane slides (P.A.L.M. Microlaser Technologies), pre-
viously radiated with UV-light (254 nm) for 30 min. For
each cup, the amount equal to 50% of the epithelium of a
transverse section of a trachea was collected within 2 h
after preparing the sections. RNA isolation and purifica-
tion were performed using RNeasy Micro Kit (Qiagen)
according to the manufacturer's protocol, but omitting
the DNA digestion step. Ten µl RNA were incubated at
70°C for 10 min. RT-mix was added (2 µl 10 × PCR buffer
II, 100 mM Tris-HCl, 500 mM KCl, pH 8.3; 4 µl MgCl2, 25
mM; 1 µl dNTPs, 10 mM; 1 µl Random Hexamers, 50 mM;
0.5 µl RNAse Inhibitor, 20 U/µl; 1 µl MuLV Reverse Tran-
scriptase, 50 U/µl; 0.5 µl H2O; all reagents from Applied
Biosystems). RNA was reverse-transcribed for 75 min at
43°C, followed by inactivation of the reverse transcriptase
by heating the RNA samples for 5 min at 99°C. For subse-
quent PCR, 4 µl cDNA, 2.5 µl 10 × PCR buffer II, 2 µl
MgCl2 (15 mM), 0.5 µl dNTPs (10 mM), 0.5 µl of each
primer (20 pM; primer sets spanning the region 25–147
for cav-1 and 392–497 for cav-2), 0.2 µl AmpliTag Gold
polymerase (5 U/µl, all reagents from Applied Biosys-
tems) and 14.8 µl H2O were applied. Cycling conditions
were 4 min at 95°C, 50 cycles with 20 s at 95°C, 20 s at
59°C, 20 s at 73°C, and a final extension at 73°C for 7
min. To control for smearing of RNA during the cutting
procedure, areas of dried O.C.T. compound (Sakura,
Zoeterwoude, The Netherlands) similar in number and
size to the samples of picked epithelial cells and directly
adjacent to the luminal side of the tracheal epithelium
were applied. Control reactions for each primer pair
included the absence of template. The PCR products were
separated by electrophoresis on a 2% TRIS-acetate-EDTA
agarose gel. Sequencing of the PCR products was done by
MWG Biotech.
Antibodies
Antibodies and their sources were as follows: anti-caveo-
lin-1α (anti-cav-1α; immunohistochemistry (IHC) 1:400,
Western blotting (WB) 1:500), polyclonal from rabbit (sc-
894; Santa Cruz Biotechnology, Heidelberg, Germany);
anti-caveolin-1αβ (anti-cav-1αβ; IHC 1:200; WB 1:500),
Table 1: Oligonucleotide primers for cav-1, cav-2 and β-MG (β-2-microglobulin) in RT-PCR analysis
Gene GenBank accession NO Primer Product length (bp) Position of amplified DNA (bp)
cav-1 Z46614.1 Forward: CAGCATGTCTGGGGGTAAAT
Reverse: TGCTTCTCATTCACCTCGTCT
123 25–147
cav-1 Z46614.1 Forward: GGCTAGCTTCACCACCTTCA
Reverse: GTGCAGGAAAGAGAGGATGG
121 165–285
cav-2 BC062059.1 Forward: TGTTTCTAGCCATCCCCTTG
Reverse: ACCATGAGGCAGGTCTTCAC
106 392–497
cav-2 BC062059.1 Forward: CCTACAGCCACCACAGTGTC
Reverse: GGTTCTGCGATCAGATCCTC
127 176–302
β-MG NM_012512 Forward: TGTCTCAGTTCCACCCACCT
Reverse: GGGCTCCTTCAGAGTGACG
191 147–337Respiratory Research 2006, 7:108 http://respiratory-research.com/content/7/1/108
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monoclonal from mouse (clone 2297; Transduction Lab-
oratories, Heidelberg, Germany); anti-caveolin-2 (anti-
cav-2; IHC 1:200), monoclonal from mouse (clone 65;
Transduction Laboratories); anti-endothelial nitric oxide
synthase (anti-eNOS; IHC 1:100), monoclonal from
mouse (clone 3; Transduction Laboratories); anti-sur-
factant protein D (anti-SP-D; IHC 1:100), monoclonal
from mouse (clone VI F11, Dianova, Hamburg, Ger-
many), anti-villin, polyclonal from rabbit (IHC 1:2,000,
[16]). Secondary antibodies used in this study for immu-
nohistochemistry were: FITC-conjugated donkey anti-
mouse-lg, F(ab')2 fragments (1:200; Dianova), Cy3-conju-
gated donkey anti-rabbit-Ig (1:2,000; Chemicon, Temec-
ula, CA, USA), Cy5-conjugated donkey anti-rabbit-Ig,
F(ab')2 fragments (1:50; Dianova), and Cy3-conjugated
donkey anti-mouse-Ig (1:1,000; Dianova). Secondary
antibodies used in this study for Western blotting were:
horseradish peroxidase-conjugated goat anti-rabbit-IgG
or horseradish peroxidase-conjugated goat anti-mouse-
IgG (both 1:10,000; Pierce, Rockford, USA).
Electron microscopy
For conventional electron microscopy, tracheae of Wistar
rats (normal conditions, n = 2), cav-1 deficient mice (SPF,
n = 2), and C57/Bl6 mice (SPF, n = 3) were prepared as
follows: The vascular system was flushed via the ascending
aorta with a rinsing solution containing heparin (2 ml/l;
10,000 U; Ratiopharm, Ulm, Germany), polyvinylpyrro-
lidone (25 g/l, MW 40.000; Roth, Karlsruhe, Germany)
and procaine hydrochloride (5 g/l; Merck, Darmstadt,
Germany) pH 7.4, followed by the fixative consisting of
1.5% glutardialdehyde and 2% paraformaldehyde (PFA)
in 0.1 M phosphate buffer (pH 7.4). Tracheae and bronchi
were dissected, stored for additional 5 h in the same fixa-
tive, washed in 0.1 M TRIS-HCl buffer, osmicated for 1 h
in aqueous 1% OsO4, washed (3 × 15 min) in 0.05 M
maleate buffer (pH 5.2), stained en block for 1 h in 1%
uranyl acetate in 0.05 M maleate buffer (pH 6.0), washed
again (3 × 5 min) in 0.05 M maleate buffer (pH 5.2),
dehydrated in ascending concentrations of ethanol and
embedded in Epon. Sections of approximately 80 nm
thickness were cut on an ultramicrotome (Reichert
Ultracut E, Leica, Bensheim, Germany) stained with alka-
line lead citrate and examined in an EM 902 transmission
electron microscope (Zeiss, Jena, Germany).
Immunohistochemistry
Unfixed tissue of Wistar rats, cav-1-deficient mice (SPF, n
= 2), wild-type mice (SPF, n = 2), and 10% neutral forma-
lin-fixed and paraffin-embedded human bronchi (n = 4)
were used for immunohistochemical analysis. Lungs from
rats and mice were inflated via the trachea with O.C.T.
compound diluted with an equal amount of 0.1 M phos-
phate buffer (pH 7.4), orientated on a piece of filter paper,
and shock-frozen in melting isopentane. Cryosections (10
µm) were cut, fixed (either with acetone at -20°C and air
dried for 10 min or with 4% PFA for 20 min and washed)
and incubated for1 h in 5% normal goat serum contain-
ing 5% BSA in 0.005 M phosphate-buffered saline (PBS).
Primary antibodies were diluted in 0.005 M phosphate
buffer containing 0.01 % NaN3 and 4.48 g/l NaCl and
applied overnight at room temperature. These antibodies
were appliedeither singly or in combination for double-
labeling immunofluorescence. Primary antibody combi-
nations were as follows: mouse anti-cav-1αβ/rabbit anti-
cav-1α; mouse anti-cav-2/rabbit anti-cav-1α; mouse anti-
eNOS/rabbit anti-cav-1α; mouse anti-SP-D/rabbit anti-
cav-1α; mouse anti-cav-2/rabbit anti-villin. After a wash-
ing step, Cy3-conjugated donkey anti-rabbit-Ig was
applied for 1 h and after a second washing step the slides
were incubated with FITC-conjugated F(ab')2 donkey anti-
mouse-Ig. Sections wererinsed, postfixed for 10 min in
4% PFA, rinsed again and coverslipped with carbonate-
buffered glycerol (pH 8.6). Sections from human bronchi
(6 µm) were deparaffinated and incubated with anti-cav-
1α and anti-cav-2 antibody as described above. Slides
were evaluated with an epifluorescence microscope
(Zeiss, Jena, Germany) using appropriate filter sets and
with a confocal laser scanning microscope (Leica-TCS SP2
AOBS;Leica, Mannheim, Germany).
Specificity of the anti-cav-1α antibody was validated by
incubation of cryosections from cav-1 deficient mice. The
specificity of the anti-cav-1αβ and anti-cav-2 antibodies
was previously shown by other groups in experiments
with cav-2 deficient mice [17]. Here, we characterized
these antibodies by Western blotting. Additional controls
included omission of the primary antibodies.
Western blot
For Western blot analysis, abraded tracheal epithelial cells
of Wistar rats (n = 5), hearts and lungs from Wistar rats,
lungs from cav-1-deficient mice and from wild-type mice
(each n = 2) were homogenized by a mixer mill (MM 300,
Qiagen) with lysis buffer containing 10 mM Tris (pH 7.5),
50 mM NaCl, 1% Triton X-100, 60 mM octylglucoside
(Sigma-Aldrich Chemie GmbH, Munich, Germany), and
one Complete Mini Protease Inhibitor Cocktail tablet
(Roche Diagnostics GmbH, Mannheim, Germany) per 10
ml buffer. After incubation of the protein solutions at 4°C
for 1 h, they were centrifugedfor 5 min at 14,000 rpm.
Equal amounts of proteins for each tissue were applied as
judged by staining of gels with Simply BlueTM Safe Stain
(Invitrogen, Carlsbad, USA) stained gels. Ten µl appropri-
ately diluted protein solution and 2 µl of 5 × sample
buffer (320 mM Tris-HCl, pH 6.8, 5% SDS, 50% glycerol,
0.25 mg/ml bromphenol blue and 1% β-2-mercaptoetha-
nol) were boiled for 5 min at 95°C. The samples were sub-
jected to 15% SDS-PAGE under reducing conditions and
subsequently transferred to a nitrocellulose membraneRespiratory Research 2006, 7:108 http://respiratory-research.com/content/7/1/108
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(Bio-Rad) by semidry blotting. The nitrocellulose mem-
branes were stained with Ponceau S to confirm the protein
transfer from the gels to the membrane. After subsequent
washing in 25 mM Tris-buffered saline with 0.05%
Tween-20 (TTBS), the unspecific binding sites were satu-
rated by incubation with 10% non-fat dry milk in TTBS
for1 h at room temperature. The membrane was incu-
bated overnight at 4°C with anti-cav-1α, -1αβ and -2, pri-
mary antibodies, diluted in 5% non-fat dry milk in TTBS.
The secondary antibodies were diluted in 2.5% non-fat
dry milk in TTBS and incubated for 1 h at room tempera-
ture. Super Signal West Pico Chemiluminescence Sub-
strate (Pierce) was used for visualization. Controls were
done by omitting the primary antibody, and the specifi-
city of the anti-cav-1α and anti-cav-2 antibodies was veri-
fied in lung homogenates from cav-1-deficient mice.
Fluorescence Resonance Energy Transfer (FRET)
FRET is a nonradiative energy transfer between two fluor-
ophores (a donor and an acceptor) that can be detected
only if the two fluorophores are less than 10 nm apart. We
used FRET combined with CLSM and double-labeling
indirect immunofluorescence as a technique for measur-
ing close spatial association of proteins in tissue sections
[18]. Cav-1 and cav-2 were labeled using conventional
indirect double-labeling immunofluorescence technique
(anti-cav-1α from rabbit labeled with Cy5-conjugated sec-
ondary reagent, anti-cav-2 antibody labeled with Cy3-
conjugated secondary reagent). Both primary antibodies
were applied simultaneously. After a washing step, Cy3-
conjugated donkey anti-mouse-Ig was applied for 1 h and
after a second washing step the slides were incubated with
Cy5-conjugated F(ab')2 donkey anti-rabbit-Ig. For control
of the species-specificity of the secondary reagents, only
the anti-cav-1 antibody and both secondary antibodies
were applied. FRET was quantified by the acceptor pho-
tobleaching method using a CLSM (TCS-SP2 AOBS,
Leica). In this method, FRET is detected by measuring the
intensity of fluorescence of the donor before and after
bleaching of the acceptor. The CLSM settings were as fol-
lows: Detection of Cy3: 52% laser power at 543 nm, detec-
tion at 555–620 nm; Cy5: 20% laser power at 633 nm,
detection at 639–738 nm. A region of interest was pho-
tobleached 10 times at 100% activity using the 633 nm
laser and maximal zoom to destroy the acceptor fluoro-
phore (Cy5) and the change in Cy3 signal (∆IF) was deter-
mined in the photobleached area where
∆IF = DDA – DDB,
DDA is the fluorescence intensity of the donor after pho-
tobleaching of the acceptor, and DDB is the fluorescence
intensity of the donor before photobleaching of the accep-
tor.
Statistical analyses
Differences among experimental group and control group
in the FRET-experiments were analysed with the Kruskal-
Wallis test followed by Mann-Whitney test using SPSS
software, version 11.5.1 (SPSS GmbH Software, Munich,
Germany), with p ≤ 0.05 being considered as significant
and p ≤ 0.01 as highly significant.
Results
RT-PCR
RT-PCR analysis of total mRNA isolated from rat lungs
and abraded tracheal epithelial cells revealed expression
of cav-1 and cav-2. PCR products were of the expected size
and the sequence was verified by sequencing. No bands
were observed in control reactions that included absence
of DNA template or the reverse transcriptase (Figure 1A).
We quantified the relative expression of cav-1 and cav-2 in
tracheal epithelial cells in rats held under standard condi-
tions or SPF conditions. In both groups, cav-2 expression
was higher than that of cav-1. Cav-2 expression levels were
22.2 times higher than that of cav-1 under standard con-
ditions and 25.8 times higher in animals housed under
SPF conditions (Figure 1B).
Laser-assisted microdissection
In accordance to the results obtained in abraded epithelial
cells, mRNA for cav-1 was detected in 17/18 samples of
microdissected tracheal epithelial cells collected from 5
rats (SPF). Cav-2 mRNA was present in all microdissected
samples (n = 15, 4 SPF rats). The identity of the PCR prod-
ucts was validated by sequencing. No mRNA for cav-1 and
cav-2 was detected in areas next to positive tissue that con-
tained O.C.T. compound only, but no cells. This result
indicates that the mRNA signal detected in the epithelium
for cav-1 and cav-2 was not caused by contamination orig-
inating from caveolin-containing adjacent cells (Figure
1A).
Western blot
Using the anti-cav-1α antibody, we detected a single band
of approximately 22 kD in rat abraded tracheal epithelial
cells (Figure 2A). A band of 22 kD and a band of 18 kD,
corresponding to cav-1β, were detected in abraded tra-
cheal epithelial cells using an anti-cav-1αβ antibody (Fig-
ure 2B). Bands of the same molecular weight were
detected in lung and heart homogenates. Using an anti-
body to cav-2, we detected a band of 15 kD (γ-isoform)
that was close to the detection limit, an 18 kD band (α-
isoform), and a 21 kD band (β-isoform) (Figure 2C). In
lung homogenates of wild-type mice, cav-1α-immunore-
active bands of 22 kD, 37 kD, and 48 kD were detected,
which were absent in lung homogenates from cav-1 defi-
cient mice (Figure 2D). Using an antibody to cav-2 for
Western blot analysis of lung homogenates from wild-Respiratory Research 2006, 7:108 http://respiratory-research.com/content/7/1/108
Page 6 of 13
(page number not for citation purposes)
type mice we detected 18 kD and 21 kD bands. No cav-2
bands were detected in lung homogenates from cav-1-
deficient mice (Figure 2E).
Immunohistochemistry
In rat, cav-1-immunoreactivity was detected in epithelial
cells of the large airways (Figure 3A). In contrast to large
cartilaginous airways, no cav-1-immunolabeling was
detected in the epithelium of the small non-cartilaginous
airways of the rat (Figure 3D). In addition, cav-1-immu-
noreactivity was observed in tracheal and bronchial
smooth muscle cells, in vascular endothelial cells and in
unidentified cells in the lamina propria, probably fibrob-
lasts. In the alveolar region, we observed cav-1-immuno-
reactivity in endothelial cells and in type I alveolar
epithelial cells.
Differences in the labeling patterns obtained with the
anti-cav-1α and the anti-cav-1αβ antibody were noted.
The labeling with the anti-cav-1α antibody was stronger in
the endothelium, whereas labeling of the anti-cav-1αβ
antibody was stronger in the epithelium (cf. Figures 3A,
B). Also, the number of the epithelial cells that were
immunoreactive for cav-1αβ was higher than that of the
cells immunoreactive for cav-1α (Figures 4A–C).
Cav-2-immunoreactivity was found in the same cell types
as cav-1-immunoreactivity. Interestingly, not all of the
cells that showed cav-2-immunofluorescence were cav-
1α-immunoreactive (Figures 4D–F). The cav-2-immu-
nolabeling of the epithelium was stronger than that of
smooth muscle cells (Figure 3C). As for cav-1, no labeling
for cav-2 was observed in the epithelial cells of the small
bronchi (Figure 3F).
Throughout the rat trachea and large bronchi, we found
cav-1α- and cav-1αβ-immunoreactivity 1) in the ciliated
cells, identified by their typical morphology and by
immunolabeling with a monoclonal antibodyto eNOS
[19] (Figure 5A), and 2) in the basal cells, identified by
their typical morphology. Unlike ciliated cells, brush cells
immunoreactive for villin were not labeled for cav-2 (Fig-
ure 5B). Most of the secretory cells that were labeled with
anti-SP-D [20] were not cav-1-immunoreactive (Figure
5C).
In human bronchi, the ciliated and the basal cells were
immunoreactive for cav-1α (Figures 5D–F). The anti-cav-
2 antibody gave no signal in paraffin-embedded human
tissue. Punctate cav-1α labeling was localized at the baso-
lateral membrane and in the apical area of the ciliated
cells underneath the luminal plasma membrane.
In the mouse respiratory epithelium, cav-1α-immunore-
activity was confined to basal cells (Figure 6D). The spe-
cificity of the cav-1-immunostaining was confirmed by
the absence of cav-1α-immunolabeling in cav-1-deficient
mice (Figure 6G).
Electron microscopy
In agreement with the immunohistochemical results, we
observed caveolae at the basolateral cell membrane of the
RT-PCR, rat Figure 1
RT-PCR, rat. (A) Cav-1 and cav-2 mRNAs were detected in abraded tracheal epithelium (TE) and in microdissected (picked) 
tracheal epithelial cells (TEC) with primer sets spanning 25–147 bp and 392–497 bp within the coding region, respectively. 
Control reactions for each primer pair included the absence of template (H20), absence of reverse transcriptase (Ø RT), and 
analysis of samples of dried O.C.T. compound that were located adjacent to the luminal side of the collected tracheal epithelial 
cells. (B) Real-time RT-PCR. CT values for β-MG, cav-1 and cav-2 derived from cDNA from abraded tracheal epithelial cells; n 
= number of animals.Respiratory Research 2006, 7:108 http://respiratory-research.com/content/7/1/108
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ciliated cells and at the cell membrane of the basal cells in
rat trachea (Figures 6A–C). Caveolae were more frequent
in basal cells. In agreement with the immunohistochemi-
cal findings in the mouse trachea, caveolae were only
found in the basal cells (Figures 6D–F). Basal cells were
devoid of caveolae in tracheae of cav-1-deficient mice
(Figures 6G–I).
CLSM-FRET in tissue sections
Conventional indirect double-labeling immunofluores-
cence with subsequent FRET-CLSM analysis was con-
ducted to determine whether cav-1 and cav-2 are in close
apposition in airway epithelial cells in situ, thereby indi-
cating an association of both proteins and formation of
hetero-oligomers. Distinct increase of fluorescence (∆IF)
was observed in the bleached area with a median value of
2.72 (n = 16 regions of interest of tracheae obtained from
4 rats; Figure 7). A false-positive FRET signal that can be
caused by cross-reactivity of secondary antibodies was
excluded by applying both secondary antibodies to sec-
tions incubated with anti-cav-1 α antibody only (median
∆IF = 0.287). Since the caveolins are membrane proteins,
we measured ∆IF in the region of the basolateral plasma
membrane. ∆IF measured in this region was higher (∆IF =
4.795) than that in the whole bleached area. The ∆IF
measured in the controls in the same region was low (∆IF
= 0.55). The difference between ∆IF observed in the exper-
imental group as compared to the corresponding controls
was highly significant (p < 0.001, Mann-Whitney test; Fig-
ure 7F). No increase in the donor fluorescence (∆IF) could
be detected in the airway epithelial cells that were immu-
noreactive for cav-2, but not for cav-1α (data not shown).
Discussion
The present study demonstrates for the first time the
expression of cav-1 and -2 in epithelial cells of the trachea
and large bronchi. Electron microscopy demonstrated
that, indeed, ciliated and basal cells possess caveolae. It
has been shown that muscarinic receptors as well as β-
adrenergic receptors may translocate to caveolae upon
agonist binding [21,22]. These receptors are involved in
the regulation of ciliary function [23,24]. In addition, sev-
eral proteins involved in Ca2+-dependent signaling proc-
esses, including the Ca2+-pump and Ca2+-ATPase, are
localized to caveolae as shown in renal and intestinal epi-
thelial cells [25]. Therefore, caveolae are likely to be
involved in the fine-tuned regulation of epithelial
cytosolic Ca2+-concentration and in regulation of ciliary
function.
Several pathogenic microorganisms selectively use caveo-
lae to enter cells [4]. Since the caveolae are localized at the
basolateral surface of the ciliated cells, it is conceivable
that they may be involved in the process of endocytosis of
infectious agents after epithelial damage. Indeed, adeno-
viruses require damage of the integrity of the epithelia or
of the tight junctions to get access to the basolateral mem-
brane of the ciliated cells to be infectious [26]. Basal cells
are much more susceptible to infection with adenoviruses
[7,27]. Accordingly, we observed more caveolae in basal
cells than in ciliated epithelial cells. It has been shown for
the adenovirus2 that it can enter the cell via its receptor
CAR that is also localized basolaterally in ciliated cells and
in basal cells. Since adenovirus2-CAR is endocytosed via
clathrin-coated pits, caveolae, at first sight, seem not to be
Western blotting Figure 2
Western blotting. (A) A single 22 kD protein was detected in abraded rat tracheal epithelium (TE) with the affinity-purified 
anti-cav-1α antibody. (B) 22 kD (α) and 18 kD (β) cav-1 protein isoforms were detected in abraded rat TE with monoclonal 
affinity-purified anti-cav-1αβ antibody. (C) 21 kD (α) and 18 kD (β) bands and, close to the detection limit, a 15 kD (γ) band, 
corresponding to the three known cav-2-isoforms, were detected with monoclonal anti-cav-2 antibody in abraded TE. (A-C) 
Heart and lung homogenates served as controls. (D) In contrast to wild-type mice (WT), no cav-1α was detected in lung 
homogenates of cav-1-deficient mice (cav-1-/-). (E) Also, no cav-2 protein was detected in lung homogenates of cav-1-deficient 
mice. The 50 kD bands in all lanes were due to the secondary antibodies that detected the heavy chain of mouse IgG.Respiratory Research 2006, 7:108 http://respiratory-research.com/content/7/1/108
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important in this process. Nevertheless, another receptor
for adenovirus2 is major histocompatibility complex
(MHC) class 1. This also is localized in the basolateral
membrane of ciliated cells and in basal cells. MHC class 1
is also the receptor for simian virus 40 that is endocytosed
via caveolae. This indicates a role for caveolae in the infec-
tion of airway epithelium by these adenoviruses. Further-
more, the infectivity of C-type human adenovirus can be
greatly reduced by the expression of a dominant negative
cav-1 mutant in plasmocytic cells indicating that caveolae
can serve as an alternative entry site for these viruses [28].
In addition, it was recently shown for Chlamydia pneu-
moniae that it co-localizes with cav-1 and cav-2 in the
cytosol in HeLa cells after cellular entrance [8], indicating
a role for caveolins in infectious processes after microbial
entry.
Since the loss of cav-1 was accompanied with loss of cave-
olae in tracheal epithelial cells in cav-1-deficient mice,
cav-1 is required for the formation of caveolae in these
cells. In addition, the stabilization and the transport of
cav-2 to the plasma membrane are dependent on the
expression of cav-1 [29,30]. Our results from FRET exper-
iments also prove that cav-1α and cav-2 are closely associ-
ated in ciliated and in basal cells, indicating that both
proteins are involved in the formation of caveolae. Inter-
estingly, we found considerably higher expression of cav-
2 mRNA than cav-1 mRNA, indicating that cav-2 could
Immunohistochemistry, rat Figure 3
Immunohistochemistry, rat. (A-C) Large airways. (A) Epithelial cells (arrows) and cells of the lamina propria were immunoreac-
tive for cav-1α. The labeling of the endothelial cells of capillaries (c) in the lamina propria was stronger compared to that of the 
epithelium. (B) Anti-cav-1αβ antibody labeled the same cell types as the anti-cav-1α antibody (arrows), however, with stronger 
intensity of the labeling in the epithelium compared to that in the lamina propria and the smooth muscle cells. (C) Epithelial 
cells (arrows) as well as cells of the lamina propria and smooth muscle cells were immunoreactive for cav-2. (D-F) Small air-
ways, bronchioli (br). Endothelial cells and type I epithelial cells of the surrounding alveoli were immunoreactive for cav-1α, 
cav-1αβ and cav-2. No immunoreactivity was detected in the bronchiolar epithelium. Epithelium = e, smooth muscle cells = m, 
lamina propria = lp.Respiratory Research 2006, 7:108 http://respiratory-research.com/content/7/1/108
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have roles independent from cav-1 once it has reached the
plasma membrane. Indeed, it has been shown for cav-2
that it associates with chlamydial inclusions independ-
ently of cav-1 [8].
We observed differences in the labeling intensities for cav-
1α and cav-1αβ among cell types. Cav-1α-immunoreac-
tivity was stronger in endothelial cells compared to epi-
thelial cells. In contrast, cav-1αβ-labeling was stronger in
the epithelium than in the endothelium of the large air-
ways. In line with this observation, Western blots showed
a strong protein expression of cav-1β in abraded tracheal
epithelium but not in lung and heart homogenates. Cav-
1β is less efficient in the formation of caveolae [31], which
could be an explanation for the lower number of caveolae
found in epithelial cells compared to endothelium where
the α-isoform is predominantly expressed [3]. The β-iso-
form of cav-1 is derived from an alternative translational
starting site that creates a protein truncated by 32 amino
acids [32] and lacks the phosphorylation site tyr 14. This
site has been shown to be phosphorylated upon stimula-
tion of cultured cells by epithelial growth factor (EGF),
leading to neoformation of caveolae [33]. Since EGF is
considered as a key factor for repair of the bronchial epi-
thelium [34], caveolae containing the α-isoform might be
involved in this process. It is tempting to speculate that
certain caveolae may exist that contain predominantly the
β-isoform. Such caveolae might be involved in other sign-
aling cascades. If both isoforms are present in caveolae,
cav-1β could be a negative regulator for signaling cascades
relying on the phosphorylation of cav-1α.
We found caveolin-1 and -2 only in the large airways of
mice and rats, limiting caveolar function to larger airways
in these species. It has to be kept in mind, however, that
many human intrapulmonary bronchi are considerably
Double-labeling immunofluorescence, CLSM, large airways, rat Figure 4
Double-labeling immunofluorescence, CLSM, large airways, rat. (A-C) Cav-1α- (A) and cav-1αβ-immunoreactivity (B) were co-
localized in the basal cells (doubled arrowheads) and basolaterally in a subset of columnar epithelial cells (arrows). Some cells 
exhibited cav-1αβ- but not cav-1α-immunoreactivity (arrowheads). (D-F) Cav-1α (D) and cav-2 (E) were localized at the baso-
lateral membrane. Co-localisation of cav-1α and cav-2 (F, arrowheads). We observed cells that were only cav-2-immunoreac-
tive (F, arrows). Epithelium = eRespiratory Research 2006, 7:108 http://respiratory-research.com/content/7/1/108
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larger than the rat trachea. Since we have found cav-1 also
in human intrapulmonary bronchi, caveolins are likely to
be present throughout a substantial part of the human
bronchial tree.
Conclusion
In summary, we conclude that ciliated and basal cells of
the trachea and large bronchi possess caveolae resulting
from an association between cav-1α and cav-2. Since cave-
olae are implied in a variety of different functions in other
cell types, they are likely to be important also for these
functions in the airway epithelium.
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arrowheads) of ciliated cells in the rat trachea. (D-I) Electron-microscopy and immunohistochemistry, wild-type mouse. Cave-
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